(Q52000613)

19 April 2018

title

Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. (English)

1 reference

19 April 2018

0 references

Gurguis GN

1

1 reference

19 April 2018

Vitton BJ

series ordinal

2

1 reference

19 April 2018

Uhde TW

series ordinal

3

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

19 April 2018

published in

Psychiatry Research

1 reference

19 April 2018

volume

71

1 reference

19 April 2018

page(s)

27-39

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

Radioimmunoassay of Plasma 17-Hydroxypregnenolone

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Cardiovascular effects of yohimbine in anaesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Stress Hormones: Their Interaction and Regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Endocrine and physiological changes during "spontaneous" panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Agonist-Promoted High Affinity State of the β-Adrenergic Receptor in Human Neutrophils: Modulation by Corticosteroids*

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

The alpha adrenoceptor antagonist properties of idazoxan in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Beta-adrenoceptor desensitization in guinea-pig isolated trachea

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

The release of catecholamines from the adrenal medulla and its modulation by alpha 2-adrenoceptors in the anaesthetized dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Ambulatory monitoring of panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Neurotransmitters involved in ACTH secretion: catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Pharmacological evidence for inhibition of ACTH secretion by a central adrenergic system in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Characteristics of the alpha-adrenergic stimulation of adrenocorticotropin secretion in rat anterior pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Influence of yohimbine on release of anterior pituitary hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Evidence for the existence of vascular alpha 2-adrenergic receptors in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Hypothalamic-pituitary-adrenocortical activity in panic disorder: Relationship to plasma catecholamine metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Autonomic and psychic effects of yohimbine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

EFFECTS OF BENZQUINAMIDE, IN COMPARISON WITH CHLORDIAZEPOXIDE AND PLACEBO, ON SUBJECTIVE EXPERIENCES AND AUTONOMIC PHENOMENA IN STRESS EXPERIMENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Glucocorticoid modulation of beta-adrenergic receptors of cultured rat arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Pharmacological characterisation of the ?-adrenoceptors responsible for a decrease of blood pressure in the nucleus tractus solitarii of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Presence of Postsynaptic α2-Adrenoreceptors of Predominantly Extrasynaptic Location in the Vascular Smooth Muscle of the Dog Hind Limb

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Chromatographic approaches to signal and selectivity enhancement for determination of biogenic amines by liquid chromatography with amperometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Effects of Yohimbine on Human Sympathetic Nervous System Function*

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Adrenergic function in patients with panic anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Endocrine and cardiovascular responses during phobic anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Glucocorticoid induction of beta-adrenergic receptors in the DDT1 MF-2 smooth muscle cell line involves synthesis of new receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Plasma catecholamines at rest and exercise in subjects with high- and low-trait anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Activation of beta 2-adrenergic receptors on mouse anterior pituitary tumor cells increases cyclic adenosine 3':5'-monophosphate synthesis and adrenocorticotropin release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Central epinergic inhibition of corticosterone release in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Liquid chromatographic assay for CSF catecholamines using electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Cardiac rate and rhythm in panic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Anxiety in patients with pheochromocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Fear and anxiety: relationship to noradrenergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Central and Peripheral α-Adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Contrasting patterns of autonomic dysfunction in patients with mitral valve prolapse and panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Situational panic attacks. Behavioral, physiologic, and biochemical characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Heart rate and blood pressure changes during postural change and isometric handgrip exercise in patients with panic disorder and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Catecholamine secretion as a function of perceived coping self-efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

10.1016/S0165-1781(97)00041-3

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

9247979

1 reference

19 April 2018